APA (7th ed.) Citation

V, P., PH, F., NH, R., SE, Y., S, C., E, W., . . . TH, D. (2025). Multicenter dose de-escalation phase I trial of pressurized intraperitoneal aerosolized chemotherapy (PIPAC) nab-paclitaxel and cisplatin in combination with systemic nab-paclitaxel in recurrent ovarian cancer patients: Trial in progress. Pleura and peritoneum, 11(1), 39. https://doi.org/10.1515/pp-2025-0036

Chicago Style (17th ed.) Citation

V, Popat, et al. "Multicenter Dose De-escalation Phase I Trial of Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) Nab-paclitaxel and Cisplatin in Combination with Systemic Nab-paclitaxel in Recurrent Ovarian Cancer Patients: Trial in Progress." Pleura and Peritoneum 11, no. 1 (2025): 39. https://doi.org/10.1515/pp-2025-0036.

MLA (9th ed.) Citation

V, Popat, et al. "Multicenter Dose De-escalation Phase I Trial of Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) Nab-paclitaxel and Cisplatin in Combination with Systemic Nab-paclitaxel in Recurrent Ovarian Cancer Patients: Trial in Progress." Pleura and Peritoneum, vol. 11, no. 1, 2025, p. 39, https://doi.org/10.1515/pp-2025-0036.